Skip to content
HowShorted

Medifast, Inc. short interest in 2018

In 2018, Medifast, Inc.'s disclosed short interest ran from 2.51% of shares outstanding on 12 Jan 2018 to 11.79% on 31 Dec 2018, a change of +9.28 percentage points. The year's high was 11.79% on 31 Dec 2018 and its low 2.00% on 28 Feb 2018, averaging 4.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.60 days on 31 Dec 2018. Full history: Medifast, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Medifast, Inc. in 2018

2018 in figures

Start of year
2.51% (12 Jan 2018)
End of year
11.79% (31 Dec 2018)
Change
+9.28 pp
High
11.79% (31 Dec 2018)
Low
2.00% (28 Feb 2018)
Average
4.50%
Highest days to cover
4.60 (31 Dec 2018)
SEC filings marked
8

Every report in 2018

Medifast, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20182.51%3.22
31 Jan 20182.30%3.60
15 Feb 20182.04%2.46
28 Feb 20182.00%3.05
15 Mar 20182.67%1.09results (8-K)
29 Mar 20182.91%1.6510-K filed
13 Apr 20183.56%2.41
30 Apr 20184.22%3.26
15 May 20184.30%2.07results (8-K), 10-Q filed
31 May 20184.20%3.31
15 Jun 20184.18%2.57
29 Jun 20183.88%1.69
13 Jul 20183.87%2.89
31 Jul 20183.77%2.97
15 Aug 20182.79%1.02results (8-K), 10-Q filed
31 Aug 20183.32%2.62
14 Sep 20183.50%1.74
28 Sep 20186.31%1.34
15 Oct 20186.20%3.13
31 Oct 20186.29%3.56
15 Nov 20185.35%1.71results (8-K), 10-Q filed
30 Nov 20186.90%3.01
14 Dec 20189.04%3.72
31 Dec 201811.79%4.60

See also: Medifast, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.